y-mabs is a startup based in France. Brouky records 2 investors associated with the company.
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing antibody-based cancer therapies focused on pediatric oncology and rare cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.